tiprankstipranks
Trending News
More News >

Jonathan McNeill Insider Profile

4 Followers
Jonathan McNeill, CBO at Dyne Therapeutics, holds 159.71K shares in Crescent Biopharma (Ticker: CBIO), holds 132.11K shares in Dyne Therapeutics (Ticker: DYN).
tipranks
Jonathan McNeill

Jonathan McNeill
Dyne Therapeutics (DYN)
CBO

Ranked #98,877 out of 106,131 Corporate Insiders

Profitable Transactions

50%
1 out of 2 Profitable Transactions

Average Return

-105.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
54.40%
45.60%
A breakdown of Jonathan McNeill's holdings

Insider Roles

Dyne Therapeutics
(DYN)
CBO
Crescent Biopharma
(CBIO)
President & COO
Roles that Jonathan McNeill holds in companies

Most Profitable Insider Trade

Stock:
Dyne Therapeutics
(DYN)
Rating:Informative Sell
Date:Mar 13, 2024 - Mar 13, 2025
Return:+57.20%
The most profitable trade made by Jonathan McNeill

Jonathan McNeill's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Dyne Therapeutics
Aug 20, 2024
CBO
Uninformative Sell
122.05K
$2.13M
Crescent Biopharma
Dec 17, 2025
President & COO
Uninformative Buy
$1.79M
List of latest transactions for each holding click on a transaction to see Jonathan McNeill's performance on stock

Jonathan McNeill insider profile FAQ

What is the percentage of profitable transactions made by Jonathan McNeill?
The percentage of profitable transactions made by Jonathan McNeill is 50%.
    What is the average return per transaction made by Jonathan McNeill?
    The average return per transaction made by Jonathan McNeill is -105.20%.
      What stocks does Jonathan McNeill hold?
      Jonathan McNeill holds: DYN, CBIO stocks.
        What was Jonathan McNeill’s latest transaction?
        Jonathan McNeill latest transaction was an Uninformative Buy of ―.
          What was Jonathan McNeill's most profitable transaction?
          Jonathan McNeill’s most profitable transaction was an Informative Sell of DYN stock on March 13, 2024. The return on the trade was 57.20%.
            What is Jonathan McNeill's role in Dyne Therapeutics?
            Jonathan McNeill's role in Dyne Therapeutics is CBO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.